The soaring investor excitement for the cannabis industry that was seen late last year into this year has been replaced by a sense of discouragement, an industry players said.
Analyst and industry experts have spoken at length about the trying summer the cannabis industry has faced recently.
One cannabis executive’s firm has suffered along with the rest of the industry, but he said it could be nearing the bottom of its most recent downturn.
Hadley Ford, CEO of iAnthus Capital Holdings (CSE:IAN,OTCQX:ITHUF), called the current struggle the sector is dealing with “a freefall of exuberance,” comparing it to the dot-com bubble burst in the mid ’90s.
During a presentation at a Canaccord Genuity investing event in October, Ford told investors the US-based multi-state operator (MSO) had been hit hard by the bear market, falling 65 percent in value year-to-date.
However, the executive told the Investing News Network (INN) there is a certain level of dissonance between market reaction and the value of individual companies.
“The actual values that exist in the market today bear no resemblance to what the value of the actual companies are,” he said.
Ford expressed confidence in the assets managed by his firm. The executive told INN, “You can go through market by market by market with us (to see) what our licenses are worth, and the actual tangible assets value of what we own is greater than the value of our company. That makes no sense whatsoever.”
This past summer was marked by a general drop in the hype-like sentiment surrounding the marijuana space, marked by an imbalance between investor expectation and the reality of company results, alongside struggles for the sector in its capital-raising ability.
For iAnthus’ part, the company recently confirmed a US$100 million financing plan in September, backed by Gotham Green Partners, to help in building out the company’s assets within its existing markets, including Arizona, Colorado, Florida and Nevada, among others.
Ford said the funding would be used to achieve cash flow generation by the second half of 2020 as the company prepares to position itself in the consumer branded goods space.
Finding capital has been a difficult feat for some MSOs in the space, however.
“We’re all getting painted with the same brush,” Ford told INN. “Six months ago, anyone who smoked a joint could raise US$100 million. Now? It’s tough.”
In the company’s results for Q2 2019, iAnthus brought in US$25 million in pro forma revenue, up 35 percent from the first quarter.
The company also noted an increase in its production and retail footprint in Florida, a coveted marijuana market. iAnthus expanded its cultivation facility in Florida to 120,000 square feet and opened an additional five dispensaries, bring its total to eight retail locations across the coastal state.
The MSO also announced the acquisition of the Nevada-based Sierra Well, a vertically integrated cannabis firm, bringing iAnthus’ footprint to six dispensaries in Nevada.
Despite iAnthus’ recent moves toward becoming cash flow positive, Ford told INN the stock is being traded at a rate four times lower than that of its peers that have what he described as very similar strategies and results.
Ford urged investors to buy into the company at its discounted rate in a recent earnings call.
Moving into 2020, Ford said the company plans on pushing its brands further into the retail market, with its line of branded “Be.” stores set to open in Brooklyn, New York, during the fourth quarter this year.
The market thus far has been driven almost solely by investor sentiment, Ford added. He said the space could be benefited by a “watershed moment,” though, not unlike the recent passing of the SAFE Banking Act through the House of Representatives.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).